Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Hoffmann, Katrin; Ganten, Tom; Gotthardtp, Daniel; Radeleff, Boris; Settmacher, Utz; Kollmar, Otto; Nadalin, Silvio; Karapanagiotou-Schenkel, Irini; von Kalle, Christof; Jaeger, Dirk; Buechler, Markus W.; Schemmer, Peter

dc.contributor.author	Nadalin, Silvio
dc.date.accessioned	2015-10-09T13:29:24Z
dc.date.available	2015-10-09T13:29:24Z
dc.date.issued	2015
dc.identifier.issn	1471-2407
dc.identifier.uri	http://hdl.handle.net/10900/65457
dc.language.iso	en	en
dc.publisher	Biomed Central Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s12885-015-1373-z
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_00754
utue.personen.roh	Hoffmann, Katrin
utue.personen.roh	Ganten, Tom
utue.personen.roh	Gotthardtp, Daniel
utue.personen.roh	Radeleff, Boris
utue.personen.roh	Settmacher, Utz
utue.personen.roh	Kollmar, Otto
utue.personen.roh	Nadalin, Silvio
utue.personen.roh	Karapanagiotou-Schenkel, Irini
utue.personen.roh	von Kalle, Christof
utue.personen.roh	Jaeger, Dirk
utue.personen.roh	Buechler, Markus W.
utue.personen.roh	Schemmer, Peter
dcterms.isPartOf.ZSTitelID	Bmc Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 392	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät